[Federal Register Volume 84, Number 41 (Friday, March 1, 2019)]
[Notices]
[Page 7129]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03689]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Siegfried 
USA, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before April 30, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
November 5, 2018, Siegfried USA, LLC, 33 Industrial Park Road, 
Pennsville, New Jersey 08070-3244 applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance             Drug code         Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid...........            2010  I
Dihydromorphine.....................            9145  I
Hydromorphinol......................            9301  I
Methylphenidate.....................            1724  II
Amobarbital.........................            2125  II
Pentobarbital.......................            2270  II
Secobarbital........................            2315  II
Codeine.............................            9050  II
Oxycodone...........................            9143  II
Hydromorphone.......................            9150  II
Hydrocodone.........................            9193  II
Methadone...........................            9250  II
Methadone intermediate..............            9254  II
Morphine............................            9300  II
Oripavine...........................            9330  II
Thebaine............................            9333  II
Opium tincture......................            9630  II
Oxymorphone.........................            9652  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers.

    Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-03689 Filed 2-28-19; 8:45 am]
 BILLING CODE 4410-09-P